[1]
|
刘疏影, 陈彪. 帕金森病流行现状[J]. 中国现代神经疾病杂志, 2016, 16(2): 98-101.
|
[2]
|
Perez-Pardo, P., Kliest, T., Dodiya, H.B., et al. (2017) The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies. Euro-pean Journal of Pharmacology, 817, 86-95. https://doi.org/10.1016/j.ejphar.2017.05.042
|
[3]
|
中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍学组. 早发型帕金森病的诊断与治疗中国专家共识[J]. 中华神经医学杂志, 2021, 20(2): 109-116.
https://doi.org/10.3760/cma.j.cn115354-20201119-00903
|
[4]
|
Yanagi, S., Sato, T., Kangawa, K., et al. (2018) The Homeostatic Force of Ghrelin. Cell Metabolism, 27, 786-804.
https://doi.org/10.1016/j.cmet.2018.02.008
|
[5]
|
Jiao, Q., Du, X., Li, Y., et al. (2017) The Neurological Effects of Ghrelin in Brain Diseases: Beyond Metabolic Functions. Neuroscience & Biobehavioral Reviews, 73, 98-111. https://doi.org/10.1016/j.neubiorev.2016.12.010
|
[6]
|
Drazen, D.L., Vahl, T.P., D’Alessio, D.A., et al. (2006) Ef-fects of a Fixed Meal Pattern on Ghrelin Secretion: Evidence for a Learned Response Independent of Nutrient Status. Endocrinology, 147, 23-30.
https://doi.org/10.1210/en.2005-0973
|
[7]
|
Poher, A.L., Tschöp, M.H. and Müller, T.D. (2018) Ghrelin Regulation of Glucose Metabolism. Peptides, 100, 236-242. https://doi.org/10.1016/j.peptides.2017.12.015
|
[8]
|
Song, B., Yan, X., Li, R., et al. (2021) Ghrelin Ameliorates Chronic Obstructive Pulmonary Disease-Associated Infllammation and Au-tophagy. Biotechnology and Applied Biochemistry, 68, 356-365.
https://doi.org/10.1002/bab.1933
|
[9]
|
Ma, Y., Zhang, H., Guo, W., et al. (2022) Potential Role of Ghrelin in the Regulation of Inflammation. FASEB Journal, 36, e22508. https://doi.org/10.1096/fj.202200634R
|
[10]
|
Slomiany, B.L. and Slomiany, A. (2013) Involvement of p38 MAPK-Dependent Activator Protein (AP-1) Activation in Modulation of Gastric Mucosal Inflammatory Responses to Helicobacter pylori by Ghrelin. Inflammopharmacology, 21, 67-78. https://doi.org/10.1007/s10787-012-0141-9
|
[11]
|
Jiao, L., Du, X., Jia, F., et al. (2021) Early Low-Dose Ghrelin In-tervention via Miniosmotic Pumps Could Protect against the Progressive Dopaminergic Neuron Loss in Parkinson’s Disease Mice. Neurobiology of Aging, 101, 70-78.
https://doi.org/10.1016/j.neurobiolaging.2021.01.011
|
[12]
|
Rees, D., Beynon, A.L., Lelos, M.J., et al. (2023) Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease. Cellular and Molecular Neurobiology, 43, 2377-2384.
https://doi.org/10.1007/s10571-022-01282-9
|
[13]
|
Chang, X., Ma, Z., Shi, L., et al. (2020) Effects of Ghrelin on the Electrical Activities of Substantia Nigra Dopaminergic Neurons Treated with MPP+. Neurochemistry International, 138, Article ID: 104780.
https://doi.org/10.1016/j.neuint.2020.104780
|
[14]
|
乔丽丽. 血清中Ghrelin、CgA、SSA、LPS水平与帕金森病的相关性研究[D]: [硕士学位论文]. 桂林: 桂林医学院, 2022.
|
[15]
|
高文明, 李嘉铮, 王慧青, 等. Ghrelin对6-OHDA诱导SH-SY5Y细胞线粒体损伤和细胞凋亡的影响[J]. 济宁医学院学报, 2021, 44(3): 179-183.
|
[16]
|
Irving, A. and Harvey, J. (2021) Regulation of Hippocampal Synaptic Function by the Metabolic Hor-mone Leptin: Implications for Health and Disease. Progress in Lipid Research, 82, Article ID: 101098.
https://doi.org/10.1016/j.plipres.2021.101098
|
[17]
|
Yang, G., Ge, H., Boucher, A., et al. (2004) Modulation of Di-rect Leptin Signaling by Soluble Leptin Receptor. Molecular Endocrinology, 18, 1354-1362. https://doi.org/10.1210/me.2004-0027
|
[18]
|
Pereira, S., Cline, D.L., Glavas, M.M., et al. (2021) Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism. Endocrine Reviews, 42, 1-28. https://doi.org/10.1210/endrev/bnaa027
|
[19]
|
Rossetti, L., Massillon, D., Barzilai, N., et al. (1997) Short Term Ef-fects of Leptin on Hepatic Gluconeogenesis and in Vivo Insulin action. Journal of Biological Chemistry, 272, 27758-27763. https://doi.org/10.1074/jbc.272.44.27758
|
[20]
|
Metlakunta, A., Huang, W., Stefanovic-Racic, M., et al. (2017) Kupffer Cells Facilitate the Acute Effects of Leptin on Hepatic Lipid Metabolism. American Journal of Physi-ology-Endocrinology and Metabolism, 312, E11-E18.
https://doi.org/10.1152/ajpendo.00250.2016
|
[21]
|
Di Spiezio, A., Sandin, E.S., Dore, R., et al. (2018) The LepR-Mediated Leptin Transport across Brain Barriers Controls Food Reward. Molecular Metabolism, 8, 13-22. https://doi.org/10.1016/j.molmet.2017.12.001
|
[22]
|
Zeng, W., Pirzgalska, R.M., Pereira, M.M., et al. (2015) Sym-pathetic Neuro-Adipose Connections Mediate Leptin-Driven Lipolysis. Cell, 163, 84-94. https://doi.org/10.1016/j.cell.2015.08.055
|
[23]
|
Shiuchi, T., Toda, C., Okamoto, S., et al. (2017) Induction of Glu-cose Uptake in Skeletal Muscle by Central Leptin Is Mediated by Muscle β2-Adrenergic Receptor But Not by AMPK. Scientific Reports, 7, Article No. 15141.
https://doi.org/10.1038/s41598-017-15548-6
|
[24]
|
Rahnemayan, S., Mirghafourvand, M., Fathalizadeh, A., et al. (2021) Leptin Levels in Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis. Clinical Nutrition ESPEN, 41, 104-109.
https://doi.org/10.1016/j.clnesp.2020.11.001
|
[25]
|
Fiszer, U., Michałowska, M., Baranowska, B., et al. (2010) Lep-tin and Ghrelin Concentrations and Weight Loss in Parkinson’s Disease. Acta Neurologica Scandinavica, 121, 230-236. https://doi.org/10.1111/j.1600-0404.2009.01185.x
|
[26]
|
Santos, N.A., Martins, N.M., Sisti, F.M., et al. (2015) The Neuroprotection of Cannabidiol against MPP+-Induced Toxicity in PC12 Cells Involves trkA Receptors, Upregulation of Axonal and Synaptic Proteins, Neuritogenesis, and Might Be Relevant to Parkinson’s Disease. Toxicology in Vitro, 30, 231-240. https://doi.org/10.1016/j.tiv.2015.11.004
|
[27]
|
Ekraminasab, S., Dolatshahi, M., Sabahi, M., et al. (2022) The Interactions between Adipose Tissue Secretions and Parkinson’s Disease: The Role of Leptin. European Journal of Neuroscience, 55, 873-891.
https://doi.org/10.1111/ejn.15594
|
[28]
|
胡敏. 硫化氢通过上调Leptin改善黑质自噬而减轻6-OHDA诱导的大鼠帕金森病样行为[D]: [硕士学位论文]. 衡阳: 南华大学, 2017.
|
[29]
|
韩铭. 瘦素对帕金森病神经损伤的保护和机制初探[D]: [硕士学位论文]. 北京: 中国人民解放军医学院, 2014.
|